A real-world analysis reveals that Shingrix is highly effective in preventing shingles in adults over 65, including those with compromised immune systems.
According to a study published in Annals of Internal Medicine, two doses of Shingrix provide better protection against shingles than a single dose.
Shingles is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. It commonly affects adults over 50, presenting as a rash with painful blisters.
Between 5% and 30% of patients with shingles experience post-herpetic neuralgia (PHN), a long-lasting nerve pain that can persist for weeks or months.
Shingrix, a recombinant zoster vaccine (RZV) manufactured by GSK, has been shown to be effective in preventing shingles in seniors.
No direct quote available in the given text.
Author's summary: Shingrix prevents shingles in seniors.